Do Vancomycin Pharmacokinetics Differ Between Obese and Non-obese Patients? Comparison of a General-Purpose and Four Obesity-Specific Pharmacokinetic Models.

Colin, Pieter J; Eleveld, Douglas J; Hart, Andrew; Thomson, Alison H

Colin, Pieter J; Eleveld, Douglas J; Hart, Andrew; Thomson, Alison H.

Afiliación

Colin PJ; Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Eleveld DJ; Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Hart A; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom; and.
Thomson AH; Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom. Hart is now with the Forth Valley Royal Hospital, NHS Forth Valley, Larbet, United Kingdom.

Ther Drug Monit ; 43(1): 126-130, 2021 02 01.

Article en En | MEDLINE | ID: mdl-33278242

Asunto(s)

Antibacterianos; Obesidad/metabolismo; Vancomicina; Antibacterianos/farmacocinética; Índice de Masa Corporal; Estudios de Cohortes; Humanos; Vancomicina/farmacocinética

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vancomicina / Antibacterianos / Obesidad Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ther Drug Monit Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google